1 option
Biopharmacological activities of medicinal plants and bioactive compounds / Ajeet Singh and Navneet Bithel, editors.
- Format:
- Book
- Series:
- Microbiology research advances series.
- Microbiology research advances
- Language:
- English
- Subjects (All):
- Materia medica, Vegetable.
- Physical Description:
- 1 online resource (428 pages)
- Place of Publication:
- New York : Nova Science Publishers, [2021]
- Summary:
- "Biopharmacological Uses of Medicinal Plants and Bioactive Compounds presents comprehensive coverage and recent advances surrounding phytopharmaceuticals, traditional and alternative systems of medicines and uses of nanotechnology in biopharmaceutical products. Sections cover the role of medicinal plants, bioactive and biophytopharmaceuticals in the management of cancer, hepatitis, HIV, analgesics, inflammation, antibacterial, viral infections, fungal infections, neurological disorders, diabetes, ENT infections, dental decay, cardiovascular disorders, skin diseases, antiproliferative etc. This volume also includes biogenic synthesis of various type of nanoparticles using medical plant extracts, seaweeds, algae, and fungi for the new drug discovery. This volume sheds new light on the immense potential of medicinal plants for human health from different technological aspects. It presents new research on bioactive compounds in medicinal plants that provide health benefits, including those that have proven especially effective in treating and managing diabetes mellitus and hypertension. It looks at the medicinal properties, antioxidant capacity, and antimicrobial activity of plants and provides scientific evidence on the use of medicinal plants in the treatment of certain diseases. Many of the plants described in the chapters are easily accessible and are believed to be effective with fewer side effects in comparison to modern drugs in the treatment of different diseases. The body of the book comprises thought-provoking and diverse chapters on the potential for utilization of plants in treating diseases of the skin and use of traditional medicine as anticancer, anti-HIV, and antibacterial agents. Each topic is introduced by providing a background on the disease, which contains updated statistics on the prevalence thereof, followed by the associated pathology, pharmacologically approved drugs currently on the market used for treatment of the disease, an array of medicinal plants used for treatment accompanied with a list of their active phytoconstituents and chemical structures thereof, as well as scientific evidence for use. This book provides key information for everyone interested in drug discovery, including medicinal chemists, nutritionists, microbiologists, biochemists, toxicologists, drug developers and health care professionals. Students, professors and researchers working in the area of pharmaceutical sciences, botany, pharmaceutical microbiology, medical microbiology and beyond will also find the book useful"-- Provided by publisher.
- Contents:
- Intro
- Contents
- Preface
- Acknowledgments
- List of Abbreviations
- Section I. Medicinal Plants in the Management of Microbial and Physiological Diseases and Disorders
- Chapter 1
- Medicinal Herbs with Analgesic and Anti-Inflammatory Properties: A Potential Source of Alternative Medicine
- Abstract
- 1. Introduction
- 2. Analgesics and Their Types
- 2.1. Types of Analgesics
- 2.1.1. Non-Opioid Painkillers
- 2.1.2. Anti-Inflammatory Drugs
- 2.1.3. Compound Painkillers
- 2.1.4. Opioid Painkillers
- 3. Inflammation and Its Types
- 3.1. Acute Phase
- 3.2. Delayed, Sub-Acute Phase
- 3.3. Chronic Proliferative Phase
- 4. Plants as Natural Source of Anti-Inflammatory and Analgesic Activities
- 4.1. Ananas comosus (L.) Merr. (Bromeliaceae)
- 4.2. Boswellia serrata Roxb. (Burseraceae)
- 4.3. Callophyllum inophyllum L. (Calophyllaceae) and Mesua ferrea L. (Calophyllaceae)
- 4.4. Calotropis gigantea (L.) Dryand. (Asclepiadaceae)
- 4.5. Calotropis procera (Aiton) W. T. Aiton (Apocynaceae)
- 4.6. Camellia sinensis (L.) Kuntze (Theaceae)
- 4.7. Cannabis sativa L. (Cannabinaceae)
- 4.8. Centella asiatica (L.) Urban (Apiaceae)
- 4.9. Curcuma longa L. (Zingiberaceae)
- 4.10. Gastrodia elata Blume (Orchidaceae)
- 4.11. Harpagophytum procumbens DC. ex Meisn. (Pedaliaceae)
- 4.12. Kalanchoe crenata Adans. (Crassulaceae)
- 4.13. Salix alba L. (Salicaceae)
- 4.14. Sida cordifolia L. (Malvaceae)
- 4.15. Zingiber officinale Roscoe (Zingiberaceae)
- 4.16. Euphorbia heterophylla L. (Euphorbiaceae)
- 4.17. Mangifera indica L. (Anacardiaceae)
- 4.18. Plumeria accuminata L. (Apocyanaceae)
- 4.19. Ricinus communis L. (Euphorbiaceae)
- 4.20. Silybum marianum L. (Asteraceae)
- 4.21. Spilanthes acmella (L.) R. K. Jansen (Asteraceae)
- 4.22. Tripterygium wilfordii Hook. f. (Celastraceae).
- 4.23. Uncaria tomentosa (Willd. ex Schult.) DC. (Rubiaceae) and U. guianensis (Rubiaceae)
- Conclusion and Future Perspectives
- References
- Chapter 2
- Herbal Compounds Used as Antibacterial Negotiator: Medicinal Plants with Antibacterial Potential
- 2. Antibacterial Bioactive Compounds
- 2.1. Alkaloids
- 2.2. Sulfur-Containing Phytochemicals
- 2.3. Terpenoids
- 2.4. Carotenoid
- 2.5. Polyphenols
- 3. Medicinal Plants with Antibacterial Activities
- 3.1. Adiantum capillus-veneris L. (Pteridaceae)
- 3.2. Agrimonia eupatoria L. (Rosaceae)
- 3.3. Ailanthus altissima (Mill.) Swingle (Simaroubaceae)
- 3.4. Alhagi maurorum Medik. (Fabaceae)
- 3.5. Allium cepa L. (Amaryllidaceae)
- 3.6. Allium sativum L. (Amaryllidaceae)
- 3.7. Alpinia galanga (L.) Willd. (Gingiberaceae)
- 3.8. Althaea rosea L. (Malvaceae)
- 3.9. Ammannia baccifera L. (Lythraceae)
- 3.10. Ammi visnaga L. (Lam.) (Apiaceae)
- 3.11. Anagyris foetida L. (Fabaceae)
- 3.12. Anchusa strigosa L. (Boraginaceae)
- 3.13. Anethum graveolens L. (Apiaceae)
- 3.14. Anthemis nobelis (L.) All. (Asteraceae)
- 3.15. Capparis spinosa L. (Cappraceae)
- 3.16. Capsicum annuum L. (Solanaceae)
- 3.17. Cassia occidentalis (L.) Link. (Fabaceae)
- 3.18. Celosia cristata L. (Amaranthaceae)
- 3.19. Centaurea cyanus L. (Asteraceae)
- 3.20. Chenopodium album L. (Amaranthaceae)
- 4. Benefits and Challenges of Phytochemicals as a Source of Antibacterial
- Chapter 3
- Neuroprotective Activities of Medicinal Plants and Natural Bioactive Compounds
- 2. Neuroprotective Effect of Plant Extracts
- 2.1. Acorus calamus L. (Araceae)
- 2.2. Actaea racemosa L. (Ranunculaceae)
- 2.3. Aframomum melegueta K. Schum. (Zingiberaceae)
- 2.4. Allium sativum L. (Amaryllidaceae).
- 2.5. Bacopa monnieri (L.) Pennell (Scrophulariaceae)
- 2.6. Carthamus tinctorius L. (Compositae)
- 2.7. Centella asiatica (L.) Urban (Apiaceae)
- 2.8. Celastrus paniculatus Wild. (Celastraceae)
- 2.9. Cinnamomum zeylanicum J. Presl (Lauraceae)
- 2.10. Curcuma longa L. (Zingeberaceae)
- 2.11. Coriandrum sativum L. (Apiaceae)
- 2.12. Curcuma zedoaria (Christm.) Roscoe (Zingiberaceae)
- 2.13. Galanthus nivalis L. (Amaryllidaceae)
- 2.14. Gastrodia elata Blume (Orchidaceae)
- 2.15. Ginkgo biloba L. (Ginkgoaceae)
- 2.16. Glycyrrhiza glabra L. (Leguminosae)
- 2.17. Hypericum perforatum L. (Hypericaceae)
- 2.18. Lycium barbarum L. (Solanaceae)
- 2.19. Lycopodium serratum (Thunb. ex Murray) Trevis. (Lycopodiaceae)
- 2.20. Melissa officinalis L. (Lamiaceae)
- 2.21. Mucuna pruriens (L.) DC. (Leguminosae)
- 2.22. Ocimum sanctum L. (Labiatae)
- 2.23. Panax ginseng Waill. Oken (Araliaceae)
- 2.24. Rosmarinus officinalis Spenn. (Lamiaceae)
- 2.25. Salvia officinalis L. (Lamiaceae)
- 2.26. Terminalia chebula Retz. (Combretaceae)
- 2.27. Tinospora cordifolia (Thunb.) Miers (Menispermaceae)
- 2.28. Withania somnifera L. (Solanaceae)
- 2.29. Zizyphus jujuba Mill. (Rhamnaceae)
- Conclusion
- Chapter 4
- Therapeutic Importance of Medicinal Plants and Natural Drugs for Diabetes Management
- 2. Diabetes
- 2.1. Types of Diabetes
- 2.1.1. Type-1 Diabetes Mellitus (DM): Insulin-Dependent Diabetes Mellitus (IDDM)
- 2.1.2. Type-2 Diabetes Mellitus: Non-Insulin-Dependent Diabetes Mellitus (NIDDM)
- 2.1.3. Gestational Diabetes Mellitus
- 2.2. Other Types of Diabetes Mellitus
- 2.3. Causes and Factors
- 3. Underlying Biochemical Signalling Pathways in the Pathogenesis of DM
- 4. Management for Diabetes Mellitus
- 4.1. Management for Type-1 Diabetes Mellitus.
- 4.2. Management for Type 2 Diabetes Mellitus
- 4.3. Synthetic Drugs for DM
- 5. Drugs from Natural Plant Origins
- 5.1. Medicinal Plants with Anti-Diabetic Properties
- 5.1.1. Allium sativum L.
- 5.1.2. Catharanthus roseus (L.) Gaterau
- 5.1.3. Eugenia jambolana (L.) Skeels
- 5.1.4. Brassica juncea (L.) Czern.
- 5.1.5. Carica papaya L.
- 5.1.6. Aegle marmelos (L.) Correa
- 5.1.7. Allium cepa L.
- 5.1.8. Gymnema sylvestre R. Br.
- 5.2. Commercial Herbal Preparations Used in the Treatment of DM
- 6. Important Natural Antioxidants Compounds Beneficial in the Management of DM
- 6.1. Flavonoids
- 6.1.1. Diosmin
- 6.1.2. Fisetin
- 6.1.3. Morin
- 6.1.4. Eriodictyol
- 6.1.5. Hesperidin
- 6.1.6. Naringenin
- 6.2. Saponins
- 6.3. Alkaloids
- 6.4. Tannins
- 6.5. Terpenes
- 7. Challenges Associated with Herbal Drugs
- Chapter 5
- Herbal Based Drug Discovery for Skin and Surgical Infectious Diseases
- 2. Different Sources of Herbal Drug
- 3. Use of Herbal Drugs to Treat Skin Infection
- 3.1. Acne
- 3.2. Psoriasis
- 3.3. Atopic Dermatitis
- 3.4. Vitiligo
- 3.5. Scabies
- 4. Use of Herbal Drugs in Surgical Site Infection
- Chapter 6
- Therapeutic Values of Medicinal Plants and Bioactive Compounds for Ear, Nose, and Throat (ENT) Diseases
- 2. Traditional Medicine (TM) and Indian Purview
- 3. Medicinal Plants: Gateway to Holistic Approach of Wellness
- 3.1. Importance of HM: A Boon to Circumvent Antibiotic Resistance (AR)
- 4. ENT Disorders and Their Treatment Protocols and the Role of Herbal Plants in the Treatment
- Chapter 7.
- Therapeutic Values of Medicinal Plants and Bioactive Phytochemicals for Mouth Infections and Dental Decay Diseases
- 2. Plant as Dental Drugs
- 3. Phyto-Constituents: In-Vivo and In-Vitro Assessments
- 4. Traditional Indian Oral Hygiene Habits
- 4.1. Chewing Sticks
- 4.2. Mouthwash
- 4.3. Tongue Cleaning
- Chapter 8
- Plants Based Herbal Drugs for Cardiovascular Diseases
- 2. Risk Factors and Pathological Mechanisms for CVDS
- 2.1. Modifiable Cardiovascular Risk Factors
- 2.1.1. Diabetes
- 2.1.2. Sedentary Lifestyle
- 2.1.3. Stress
- 2.1.4. Consumption of Alcohol, Tobacco and Smoking
- 2.1.5. Unhealthy Diet
- 2.1.6. Disturbed Lipid Profile
- 2.1.7. Hypertension
- 2.1.8. Obesity
- 2.2. Non-Modifiable Cardiovascular Risk Factors
- 3. Herbal Remedies in the Management of Cardiovascular Diseases
- 4. Cardioprotective Herbs and Nutraceuticals for Hypertension
- 5. Cardioprotective Natural Products for Ischemic Heart Disease (IHD) and Congestive Heart Failure (CHF)
- 5.1. Flavonoids
- 5.2. Resveratrol
- 5.3. Lycopene (Carotenoids)
- 5.4. Omega-3 Fatty Acids
- 5.5. Olive Oil
- 5.6. Soy
- 5.7. Cardiac Glycosides
- 6. Cardioprotective Natural Products for Angina Pectoris
- 7. Natural Products for Cerebrovascular Disorders
- 7.1. Ginkolides and Bilobalides
- 7.2. Sulphated Polysaccharides
- 7.3. Garlic Thiosulphinates
- Chapter 9
- Role of Traditional Practices and Ethno-Medicinal Plants for the Management of Jaundice and Hepatic Diseases
- 2. Ethnopharmacological Approaches for Management of Jaundice
- 2.1. Jaundice and Different beliefs World Wide
- 3. Traditional Practices in India.
- 4. Ethnobotanical Approach for Treatment of Jaundice in Uttarakhand.
- Notes:
- Description based on print version record.
- Includes bibliographical references and index.
- ISBN:
- 1-68507-056-6
- OCLC:
- 1266906853
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.